-
Products in the pipeline
It is an exciting time in the treatment of people with bleeding disorders with many coagulation products having been recently approved by Health Canada or “in the pipeline” at...
WFH publishes 3rd Edition of the Guidelines for the Management of Hemophilia
The World Federation of Hemophilia (WFH) has published the 3rd Edition of the Guidelines for the Management of Hemophilia, replacing the 2nd Edition published in 2012. The 158-page document...
FDA denies approval of Biomarin’s FVIII gene therapy
In a decision that surprised many, the U.S. Food and Drug Administration (FDA) last week denied approval of Biomarin’s FVIII gene therapy, branded Roctavian. The therapy has also been...
INNOVATORS
BUILDER
Believers
